Inhibitor binding tertiary structure

The basic kinetic properties of this allosteric enzyme are clearly explained by combining Monod s theory and these structural results. The tetrameric enzyme exists in equilibrium between a catalytically active R state and an inactive T state. There is a difference in the tertiary structure of the subunits in these two states, which is closely linked to a difference in the quaternary structure of the molecule. The substrate F6P binds preferentially to the R state, thereby shifting the equilibrium to that state. Since the mechanism is concerted, binding of one F6P to the first subunit provides an additional three subunits in the R state, hence the cooperativity of F6P binding and catalysis. ATP binds to both states, so there is no shift in the equilibrium and hence there is no cooperativity of ATP binding. The inhibitor PEP preferentially binds to the effector binding site of molecules in the T state and as a result the equilibrium is shifted to the inactive state. By contrast the activator ADP preferentially binds to the effector site of molecules in the R state and as a result shifts the equilibrium to the R state with its four available, catalytically competent, active sites per molecule. 

Type I antiestrogens are competitive inhibitors of the binding of estrogens to ER. As demonstrated for raloxifene, these compounds seem to form a complex with the ER that retains partial transcription activity as a result of imperfect changes in the tertiary structure of the complex (Brzozowski et al. 

In a very broad overview of the structural categories one can state several statistical correlations with type of function. Hemes are almost always bound by helices, but never in parallel a//3 structures. Relatively complex enzymatic functions, especially those involving allosteric control, are occasionally antiparallel /3 but most often parallel a//3. Binding and receptor proteins are most often antiparallel /3, while the proteins that bind in those receptor sites (i.e., hormones, toxins, and enzyme inhibitors) are most apt to be small disulfide-rich structures. However, there are exceptions to all of the above generalizations (such as cytochrome cs as a nonhelical heme protein or citrate synthase as a helical enzyme), and when one focuses on the really significant level of detail within the active site then the correlation with overall tertiary structure disappears altogether. For almost all of the dozen identifiable groups of functionally similar proteins that are represented by at least two known protein structures, there are at least... 

While no MEK apo structures have been published, comparisons to the catalytic domains of similar kinases reveal a number of differences versus the tertiary structure of MEKl. Relative to a crystal structure of PKA, there is an outward rotation of the N-terminal portion of hehx C by approximately 10 A and the formation of a short, two-turn a-hehcal segment of the activation loop. Both of these changes give rise to the allosteric binding pocket which enables the unique binding mode. Inhibitors such as PD318088 stabi-... 

It was originally assumed that in LADH the zinc existed in an octahedral form with six bonds available for coordination, until in 1967 Vallee and co-workers showed that the enzyme contained two different types of zinc atom.13773 Loss of two zinc atoms from the enzyme resulted in loss of catalytic activity but maintained the tertiary structure. It was postulated from this that one metal ion per subunit played a role maintaining the tertiary structure, while the other zinc functioned in a catalytic role. Only two of the zinc ions in the liver enzyme interact with the inhibitors 1,10-phenanthroline and 2,2 -bipyridyl, thus demonstrating the different chemical reactivities of the zinc ions.1378 It was also shown that one zinc per subunit could be selectively exchanged or removed by dialysis. This modified enzyme containing one zinc per subunit did not bind 1,10-phenanthroline, hence the catalytic zinc is removed first during dialysis.1379 The second zinc atom can be selectively removed in preference to the catalytic zinc, by carboxymethylation followed by dialysis.1377 ... 

The primary, secondary, and presumably tertiary, and higher, structure of the family of facilitative glucose transporters are similar. It is beginning to be understood which domains of these transporters are important for substrate and inhibitor binding and for subcellular localization. Future work will undoubtably uncover the molecular mechanism by which the facilitative transporters catalyze the translocation of sugars across the membrane. 

The stress-70 proteins interact with a broad spectrum of polypeptide substrates, but they have some degree of specificity in their interactions. In several instances, it has been shown that a stress-70 protein can bind to proteins [e.g., bovine pancreatic trypsin inhibitor (BPTI), a-lactalbumin] that have been stabilized in a nonnative, or denatured, form by reduction and carboxymethylation of the cysteines that would normally form disulfides at the same time, they will not bind to the native forms of the same proteins (Liberek et al., 1991b Palleros et ai, 1991, 1992). This suggests that the peptide-binding activity of the stress-70 proteins discriminates in favor of polypeptides in a denatured, and possibly extended, conformation over those in a compact secondary and tertiary structure. NMR experiments demonstrating that the E. coli dnaK... 

Noncompetitive inhibitors interact reversibly with enzymes to form an inactive species, effectively removing active enzyme and thus interfering with the rate of conversion of substrate to product. The inhibitor may interact with free enzyme, or with the enzyme-substrate complex. The key feature of noncompetitive inhibition that distinguishes it from competitive inhibition is that inhibition does not affect the apparent affinity of the enzyme for its substrate (i.e., the apparent Km). For example, a noncompetitive inhibitor may bind in a region remote from the active site to cause a reversible change in enzyme tertiary structure that completely prevents substrate binding and product formation. In this type of inhibition, the quantity of active enzyme appears to decrease as inhibitor concentration increases, so that the apparent Fmax for the reaction decreases. 

In spite of the overall similarity of tertiary structure, a detailed analysis of the binding of inhibitors (Fig. 10), shows important differences in inhibitor-binding properties between the classes. In the short spacer family, the inhibitor is bound in an extended conformation while in the thermolysin family inhibitors adopt a twisted conformation. The contrasting requirements of the two classes is illustrated by the selectivity of the classical non-specific zinc-pro-tease inhibitor phosphoramidon which is active in nanomolar concentrations against the thermolysin-like enzymes [28] but has little or no inhibitory activity against the enzymes of the short spacer family [42]. 

Many chemicals can bind to enzymes and either eliminate or drastically reduce their catalytic ability. These chemicals, called enzyme inhibitors, have been used for hundreds of years. When she poisoned her victims with arsenic, Lucretia Borgia was unaware that it was binding to the thiol groups of cysteine amino acids in the proteins of her victims and thus interfering with the formation of disulfide bonds needed to stabilize the tertiary structure of enzymes. However, she was well aware of the deadly toxicity of heavy metal salts like arsenic and mercury. When you take penicillin for a bacterial infection, you are taking another enzyme inhibitor. Penicillin inhibits several enzymes that are involved in the synthesis of bacterial cell walls. 

Bovine Pancreatic Trypsin Inhibitor (BPTI) is one of the smallest and simplest globular proteins. BPTI s sole function is to bind to and inhibit proteolytic enzymes like trypsin. BPTI contains both ot helical and sheet regions, as well as three disulfide bonds, which help to stabilize the tertiary structure of the molecule. 

Other cases of inhibition involve the binding of the inhibitor to a site other than the site where substrate binds. For example, the inhibitor can bind to the enzyme on the outside of the protein and thereby alter the tertiary structure of the enzyme so that its substrate binding site is unable to function. Because some of the enzyme is made nonfunctional, adding more substrate can t reverse the inhibition. Vmax, the kinetic parameter that includes the Et term, is reduced. The binding of the inhibitor can also affect Km if the enzyme-inhibitor complex is partially active. Inhibitors that alter both Vmax and Km are called noncompetitive the rare inhibitors that alter Vmax only are termed uncompetitive. 

The information available provides useful constraints on preliminary models of the tertiary structure. As we have previously pointed out (1,2), based on the reaction center model for which the structure is known (cf. 13), residues which are modified in inhibitor resistance strains are likely to map in the tertiary structure to the same volume as the catalytic site at which the inhibitor binds. Together with the heme ligands, which fix the relative positions of helices B and D, the resistance mutations suggest that helices A,D and E should be close at the cytoplasmic ends, while helices C,E, and F should be close at their periplasmic ends. Amphipathic helix cd (at it s N-terminal end) has several mutations on the same side of the helix, and these need to interface with the same volume. Orientation of the helices is indicated by their mutability moment. A preliminary model including these constraints, with helices A-H vertical has been suggested (2), but will obviously need refinement as new information on spatial relationships becomes available. 

---